What is the treatment for Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Diabetic Ketoacidosis (DKA)

The management of DKA requires immediate fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour or 1-1.5 L in the first hour, followed by continuous intravenous regular insulin at 0.1 U/kg/hour without bolus, and careful electrolyte monitoring and replacement. 1

Diagnosis and Severity Assessment

DKA is characterized by:

  • Hyperglycemia (typically >250 mg/dL, though euglycemic DKA can occur)
  • Metabolic acidosis (pH <7.3, serum bicarbonate <18 mEq/L)
  • Elevated ketones in blood or urine 1, 2

Severity classification:

Parameter Mild Moderate Severe
Arterial pH 7.25-7.30 7.00-7.24 <7.00
Bicarbonate (mEq/L) 15-18 10-14 <10
Mental Status Alert Alert/drowsy Stupor/coma

Treatment Algorithm

1. Fluid Resuscitation

  • First hour: Infuse isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour or 1-1.5 L to expand intravascular volume and restore renal perfusion 1
  • Subsequent hours: Continue fluid replacement based on hemodynamic status and electrolyte levels
  • Goal: Correct dehydration, improve tissue perfusion, and enhance insulin sensitivity

2. Insulin Therapy

  • Initial: Start continuous IV regular insulin at 0.1 U/kg/hour without bolus 1
    • Recent evidence shows insulin boluses increase adverse effects (particularly hypokalemia) without significantly improving time to DKA resolution 3
  • Adjustment: Titrate insulin to achieve blood glucose reduction of approximately 50 mg/dL per hour 4
  • Transition: When DKA resolves (glucose <200 mg/dL, bicarbonate ≥18 mEq/L, venous pH >7.3), administer subcutaneous basal insulin 2-4 hours before stopping IV insulin to prevent rebound hyperglycemia 5, 1

3. Electrolyte Management

  • Potassium: Check levels every 4-6 hours initially 1
    • If K+ <3.3 mEq/L: Hold insulin and give potassium replacement until >3.3 mEq/L
    • If K+ 3.3-5.3 mEq/L: Add 20-30 mEq potassium to each liter of IV fluid
    • If K+ >5.3 mEq/L: Withhold potassium replacement and monitor closely
  • Phosphate: Consider replacement if severe hypophosphatemia develops
  • Bicarbonate: Generally not recommended unless severe acidosis (pH <7.0) persists 5

4. Glucose Monitoring and Adjustment

  • Check blood glucose every 1-2 hours until stable
  • When glucose reaches 200 mg/dL, add dextrose to IV fluids (D5W or D10W) and continue insulin infusion to clear ketones 1, 6

5. Monitoring for Complications

  • Cerebral edema: Monitor for headache, altered mental status, seizures, or bradycardia
  • Hypokalemia: Most common electrolyte abnormality during treatment
  • Hypoglycemia: Risk increases as ketoacidosis resolves
  • Hyperchloremic metabolic acidosis: Can develop during treatment due to large volumes of normal saline

Special Considerations

ICU Admission Criteria

Patients should be admitted to ICU if they present with:

  • Arterial pH <7.00
  • Altered mental status (stupor/coma)
  • Hemodynamic instability
  • Severe hyperosmolarity (>320 mOsm/kg) 1

Resolution Criteria

DKA is considered resolved when:

  • Blood glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3 1

Transition to Subcutaneous Insulin

  • Administer basal insulin 2-4 hours before stopping IV insulin 5, 1
  • Consider adding mealtime insulin as appropriate
  • Avoid interruption in insulin therapy to prevent recurrence of ketoacidosis 7

Prevention of Recurrence

  • Identify and treat precipitating factors (infection, medication non-adherence, etc.)
  • Provide comprehensive diabetes education
  • Ensure access to insulin and supplies
  • Regular follow-up with healthcare providers 2

The mortality rate for DKA is approximately 5%, with worse outcomes in patients of extreme ages and those presenting with coma or hypotension 1. Prompt recognition and appropriate management following the above protocol can significantly improve outcomes.

References

Guideline

Metabolic Alkalosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of diabetic ketoacidosis.

Indian journal of pediatrics, 2011

Research

Basal insulin for the management of diabetic ketoacidosis.

European journal of internal medicine, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.